Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics - NEWS IN MALAYALAM

news in malayalam is a news web site

Breaking

Home Top Ad

Responsive Ads Here

Post Top Ad

Responsive Ads Here

Wednesday, May 8, 2019

Alphabet's GV Leads Funding in Gene Editing Company Verve Therapeutics

GV led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.

No comments:

Post a Comment

Post Bottom Ad

Responsive Ads Here

Pages